These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9592266)

  • 41. Sialochemistry of patients with rheumatoid arthritis. Electrolytes, protein, and salivary IgA.
    Ben-Aryeh H; Nahir M; Scharf Y; Gutman D; Laufer D; Szargel R
    Oral Surg Oral Med Oral Pathol; 1978 Jan; 45(1):63-70. PubMed ID: 271289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
    Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
    Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
    Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic suppurative parotitis: a proposed classification.
    Wang S; Zou Z; Wu Q; Sun K; Ma X; Zhu X
    Chin Med J (Engl); 1996 Jul; 109(7):555-60. PubMed ID: 9206105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
    Hernández CC; Donadi EA; Reis ML
    J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary resistin reflects local inflammation in Sjögren's syndrome.
    Boström EA; d'Elia HF; Dahlgren U; Simark-Mattsson C; Hasséus B; Carlsten H; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 Oct; 35(10):2005-11. PubMed ID: 18709689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysozyme concentration in saliva of patients with Sjögren's syndrome.
    Hené RJ; Kater L
    J Rheumatol; 1991 Jan; 18(1):150-1. PubMed ID: 2023190
    [No Abstract]   [Full Text] [Related]  

  • 48. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome.
    Manoussakis MN; Dimitriou ID; Kapsogeorgou EK; Xanthou G; Paikos S; Polihronis M; Moutsopoulos HM
    Arthritis Rheum; 1999 Feb; 42(2):229-39. PubMed ID: 10025916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
    Mignogna MD; Fedele S; Lo Russo L; Lo Muzio L; Wolff A
    J Oral Pathol Med; 2005 Jan; 34(1):1-6. PubMed ID: 15610399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment.
    Peluso G; De Santis M; Inzitari R; Fanali C; Cabras T; Messana I; Castagnola M; Ferraccioli GF
    Arthritis Rheum; 2007 Jul; 56(7):2216-22. PubMed ID: 17599740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Mixed and palatal salivary secretion in denture-wearing healthy people and in patients with Sjogren syndrome].
    Márton K; Boros I; Lesti A; Hermann P; Faluhelyi P; Fejérdy P
    Fogorv Sz; 2002 Apr; 95(2):67-71. PubMed ID: 11980425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
    Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
    Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A sialochemical study on patients with Sjögren's syndrome.
    Benedek-Spät E; Berényi B; Csiba A
    Arch Oral Biol; 1975 Oct; 20(10):649-52. PubMed ID: 1059387
    [No Abstract]   [Full Text] [Related]  

  • 56. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
    Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
    Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential involvement of subclinical Sjögren's syndrome in various lung diseases.
    Kurumagawa T; Kobayashi H; Motoyoshi K
    Respirology; 2005 Jan; 10(1):86-91. PubMed ID: 15691243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
    Steinfeld SD; Tant L; Burmester GR; Teoh NK; Wegener WA; Goldenberg DM; Pradier O
    Arthritis Res Ther; 2006; 8(4):R129. PubMed ID: 16859536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.